Open access · CC-BY
via OpenAlex
Acceleration of leukocytes’ epigenetic age as an early tumor and sex-specific marker of breast and colorectal cancer
Danielle Fernandes Durso, Maria Giulia Bacalini, Claudia Sala, Chiara Pirazzini, Elena Marasco, Massimiliano Bonafè, Ítalo Faria do Valle, Davide Gentilini, Gastone Castellani, Ana Maria Caetano Faria, Claudio Franceschi, Paolo Garagnani, Christine Nardini
Oncotarget · 2017 · ▲ 116 citations
Abstract
// Danielle Fernandes Durso 1, 2, * , Maria Giulia Bacalini 3, * , Claudia Sala 4, 9 , Chiara Pirazzini 3 , Elena Marasco 1 , Massimiliano Bonafé 1 , Ítalo Faria do Valle 4 , Davide Gentilini 5 , Gastone Castellani 4, 9 , Ana Maria Caetano Faria 6 , Claudio Franceschi 3, * , Paolo Garagnani 1, 7, 8, 9, * , Christine Nardini 10, 11, * 1 Department of Experimental, Diagnostic and Specialty Medicine, Alma Mater Studiorum-University of Bologna, Bologna, Italy 2 National Counsel of Technological and Scientific Development (CNPq), Ministry of Science Technology and Innovation (MCTI), Brasilia, Brazil 3 IRCCS Istituto delle Scienze Neurologiche di Bologna, Bologna, Italy 4 Department of Physics and Astronomy, University of Bologna, Bologna, Italy 5 Istituto Auxologico Italiano IRCCS, Cusano Milanino, Milan, Italy 6 Biochemistry and Immunology Department, Biological Sciences Institute, Federal University of Minas Gerais, Belo Horizonte, Brazil 7 Applied Biomedical Research Center, S. Orsola-Malpighi Polyclinic, Bologna, Italy 8 Interdepartmental Center “L. Galvani”, University of Bologna, Bologna, Italy 9 Clinical Chemistry, Department of Laboratory Medicine, Karolinska Institutet at Huddinge University Hospital, Stockholm, Sweden 10 Personal Genomics S.r.l., Verona, Italy 11 CNR IAC “Mauro Picone”, Rome, Italy * These authors contributed equally to this work Correspondence to: Christine Nardini, email: [email protected] Paolo Garagnani, email: [email protected] Claudio Franceschi, email: [email protected] Keywords: epigenetic clock(definition), ELOVL2, FHL2, cancer, blood Received: October 19, 2016 Accepted: February 12, 2017 Published: February 21, 2017 ABSTRACT Changes in blood epigenetic age have been associated with several pathological conditions and have recently been described to anticipate cancer development. In this work, we analyze a publicly available leukocytes methylation dataset to evaluate the relation between DNA methylation age and the prospective development of specific types of cancer. We calculated DNA methylation age acceleration using five state-of-the-art estimators (three multi-site: Horvath, Hannum, Weidner; and two CpG specific: ELOV2 and FHL2) in a cohort including 845 subjects from the EPIC-Italy project and we compared 424 samples that remained cancer-free over the approximately ten years of follow-up with 235 and 166 subjects who developed breast and colorectal cancer, respectively. We show that the epigenetic age estimated from blood DNA methylation data is statistically significantly associated to future breast and male colorectal cancer development. These results are corroborated by survival analysis that shows significant association between age acceleration and cancer incidence suggesting that the chance of developing age-related diseases may be predicted by circulating epigenetic markers, with a dependence upon tumor type, sex and age estimator. These are encouraging results towards the non-invasive and perspective usage of epigenetic biomarkers.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.18632/oncotarget.15573
- Canonical
- link ↗
- Fetched
- 2026-09-09 MST
Cite this
APA
Durso, D.F., Bacalini, M.G., Sala, C., Pirazzini, C., Marasco, E., Bonafè, M., Valle, �.F.D., Gentilini, D., Castellani, G., Faria, A.M.C., Franceschi, C., Garagnani, P., & Nardini, C. (2017). Acceleration of leukocytes’ epigenetic age as an early tumor and sex-specific marker of breast and colorectal cancer. <em>Oncotarget</em>. https://doi.org/10.18632/oncotarget.15573
Vancouver
Durso DF, Bacalini MG, Sala C, Pirazzini C, Marasco E, Bonafè M, et al. Acceleration of leukocytes’ epigenetic age as an early tumor and sex-specific marker of breast and colorectal cancer. Oncotarget. 2017. doi:10.18632/oncotarget.15573.
BibTeX
@article{danielle2017Accele,
title = {Acceleration of leukocytes’ epigenetic age as an early tumor and sex-specific marker of breast and colorectal cancer},
author = {Danielle Fernandes Durso and Maria Giulia Bacalini and Claudia Sala and Chiara Pirazzini and Elena Marasco and Massimiliano Bonafè and Ítalo Faria do Valle and Davide Gentilini and Gastone Castellani and Ana Maria Caetano Faria and Claudio Franceschi and Paolo Garagnani and Christine Nardini},
journal = {Oncotarget},
year = {2017},
doi = {10.18632/oncotarget.15573},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Archives of Dermatological Research 2024
Citation only
Signatures of epigenetic, biological and mitotic age acceleration and telomere shortening are associated with arsenic-induced skin lesions
Nutrition Metabolism and Cardiovascular Diseases 2026
Open access · CC-BY
Epigenetic age acceleration in adolescence: cross-sectional associations with dietary intake and prospective associations with cardiometabolic risk indicators in a Mexico City cohort
TruDiagnostic 2022
Open access · US-GOV
The Impact of a Human Breast Milk Supplement on Epigenetic and Cellular Markers
Clinical Epigenetics 2016
Open access · CC-BY
Frailty is associated with the epigenetic clock but not with telomere length in a German cohort
UNC Lineberger Comprehensive Cancer Center 2014
Open access · US-GOV
LCCC 1410: Impact of Physical Activity on Biomarker of Aging and Body Composition Among Breast Cancer Survivors Age 65 and Older
GeroScience 2022
Open access · CC-BY